Amyloid β peptide-induced corpus callosum damage and glial activation in vivo

NeuroReport

Volumn 14, Issue 11, 2003, Pages 1429-1433

  Jantaratnotai, Nattinee ^a   Ryu, Jae K ^a   Kim, Seung U ^a,b   McLarnon, James G ^a  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^b Ajou University   (South Korea)

Author keywords

Alzheimer's disease; Amyloid peptide; Astrocytes; Corpus callosum; Microglia; Myelin; Neurofilament; Oligodendrocytes

Indexed keywords

AMYLOID BETA PROTEIN; MYELIN;

ALZHEIMER DISEASE; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; ASTROCYTE; BRAIN INJURY; CELL FUNCTION; CONTROLLED STUDY; CORPUS CALLOSUM; DEMYELINATION; GLIA; IMMUNOCYTOCHEMISTRY; IMMUNOREACTIVITY; MALE; MICROGLIA; NEUROFILAMENT; NONHUMAN; OLIGODENDROGLIA; PATHOPHYSIOLOGY; PRIORITY JOURNAL; STAINING; WHITE MATTER;

AMYLOID BETA-PROTEIN; ANIMALS; ASTROCYTES; AXONS; COLORING AGENTS; CORPUS CALLOSUM; GLIAL FIBRILLARY ACIDIC PROTEIN; GLIOSIS; IMMUNOHISTOCHEMISTRY; MACROPHAGE ACTIVATION; MALE; MICROSCOPY, FLUORESCENCE; MYELIN SHEATH; NERVE FIBERS; NEUROGLIA; OLIGODENDROGLIA; PEPTIDE FRAGMENTS; RATS; RATS, SPRAGUE-DAWLEY; STEREOTAXIC TECHNIQUES;

EID: 0041330612     PISSN: 09594965     EISSN: None     Source Type: Journal    
DOI: 10.1097/00001756-200308060-00005     Document Type: Article

References (26)

1. Selkoe DJ. Neuron 6, 487-498 (1991).
2. Yankner BA. Neuron 16, 921-932 (1996).
3. Selkoe DJ. Physiol Rev 81, 741-766 (2001).
4. Wisniewski HM, Bancher C, Barcikowska M et al. Acta Neuropathol 78, 337-347 (1989).
5. Iwamoto N, Nishiyama E, Ohwada J et al. Acta Neuropathol 93, 334-340 (1997).
6. Roher AE, Weiss N, Kokjohn TA et al. Biochemistry 41, 11080-11090 (2002).
7. Biegon A, Eberling JL, Richardson BC et al. Neurobiol Aging 15, 393-397 (1996).
8. Janowsky JS, Kaye JA and Carper RA. J Am Geriatr Soc 44, 798-803 (1996).
9. Hampel H, Teipel SJ, Alexander GE et al. J Neural Transm 109, 837-855 (2002).
10. Teipel SJ, Bayer W, Alexander GE et al. Arch Neurol 59, 243-248 (2002).
11. Xu J, Chen S, Ahmed SH et al. J Neurosci 21, 1RC118 (1-5), (2001).
12. Lassmann H, Bancher C, Breitschopf H et al. Acta Neuropathol 89, 35-41 (1995).
13. Walker DG, Lue LF and Beach TG. Neurobiol Aging 22, 957-966 (2001).
14. Weldon DT, Rogers SD, Ghilardi JR et al. J Neurosci 18, 2161-2173 (1998).
15. Lehmann M, Fournier A, Selles-Navarro I et al. J Neurosci 19, 7537-7547 (1999).
16. Brun A and Englund E. Ann Neurol 19, 253-262 (1986).
17. de la Monte SM. Ann Neurol 25, 450-459 (1989).
18. Holtzman DM, Bales KR, Tenkova T et al. Proc Natl Acad Sci USA 97, 2892-2897 (2000).
19. Kobayashi K, Hayashi M, Nakano H et al. Neuropathol Appl Neurobiol 28, 238-251 (2002).
20. Merrill JE, Ignarro LJ, Sherman MP et al. J Immunol 151, 2132-2141 (1993).
21. Smith KJ, Kapoor R and Felts PA. Brain Pathol 9, 69-92 (1999).
22. Xie Z, Wei M, Morgan TE et al. J Neurosci 22, 3484-3492 (2002).
23. Popovic N, Schubart A, Goetz BD et al. Ann Neurol 51, 215-223 (2002).
24. Rogers J, Luber-Narod J, Styren SD et al. Neurobiol Aging 9, 339-349 (1988).
25. Sheng JG, Mrak RE and Griffin WS. Neuropathol Appl Neurobiol 21, 290-301 (1995).
26. Rogers J, Webster S, Lue LF et al. Neurobiol Aging 17, 681-686 (1996).